Prognostic values of ADC(mean) and SUVmax of the primary tumour in cervical cancer patients treated with definitive chemoradiotherapy

dc.contributor.authorYildirim, Berna Akkus
dc.contributor.authorOnal, Cem
dc.contributor.authorErbay, Gurcan
dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorKaradeli, Elif
dc.contributor.authorReyhan, Mehmet
dc.contributor.authorKoc, Zafer
dc.contributor.orcID0000-0002-2742-9021en_US
dc.contributor.orcID0000-0003-0987-1980en_US
dc.contributor.pubmedID30354907en_US
dc.contributor.researcherIDD-5195-2014en_US
dc.contributor.researcherIDS-8384-2016en_US
dc.date.accessioned2021-02-28T13:58:10Z
dc.date.available2021-02-28T13:58:10Z
dc.date.issued2019
dc.description.abstractWe analysed the correlation of F-18-fluorodeoxyglucose uptake into primary tumours using the maximum standardised uptake value (SUVmax) and the mean apparent diffusion coefficient (ADC(mean)) values in magnetic resonance imaging (MRI) with the clinical and pathological factors in patients with cervical cancer who were treated with concurrent chemoradiotherapy. The patients were stratified according to the primary tumour pre-treatment ADC(mean) and SUVmax cut-off values. There were significant correlations between the SUVmax of the primary tumour and tumour size, and the treatment response. The correlation between the ADC(mean) and FIGO stage, tumour size, and the lymph node metastasis was significant. The SUVmax was significantly and inversely correlated with the ADC(mean) for cervical cancer (r = -0.44, p <.001). In the multivariate analysis, the primary tumour ADC(mean), treatment response and the lymph node metastasis emerged as significant independent predictors of both OS and DFS, and of the primary tumour SUVmax for DFS. Tumour size has a borderline significance for OS. High SUVmax and low ADC(mean) of the primary tumour are important predictive factors for identifying high-risk patients with cervical cancer who are treated with definitive chemoradiotherapy. These results point to a future role for the diffusion-weighted MRI and for F-18-fluorodeoxyglucose positron emission tomography, not only in the staging of cervical cancer but as an aid in the selection of an adjuvant treatment regimen after chemoradiotherapy for individual patients.en_US
dc.identifier.endpage230en_US
dc.identifier.issn0144-3615en_US
dc.identifier.issue2en_US
dc.identifier.startpage224en_US
dc.identifier.urihttp://hdl.handle.net/11727/5441
dc.identifier.volume39en_US
dc.identifier.wos000458238400015en_US
dc.language.isoengen_US
dc.relation.isversionof10.1080/01443615.2018.1492528en_US
dc.relation.journalJOURNAL OF OBSTETRICS AND GYNAECOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCervical canceren_US
dc.subjectchemoradiotherapyen_US
dc.subjectpositron emission tomographyen_US
dc.subjectmagnetic resonance imagingen_US
dc.subjectprognostic factoren_US
dc.titlePrognostic values of ADC(mean) and SUVmax of the primary tumour in cervical cancer patients treated with definitive chemoradiotherapyen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: